Stay updated on UNR844-Cl Eye Drops in Presbyopia: Clinical Trial

Sign up to get notified when there's something new on the UNR844-Cl Eye Drops in Presbyopia: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UNR844-Cl Eye Drops in Presbyopia: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a new version of the page. This reflects a page-level update rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-05-17T08:38:34.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s footer “Revision” was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T18:47:07.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces v3.5.0. No visible changes to the study details on the page.
    Difference
    0.1%
    Check dated 2026-04-18T13:33:39.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.0 and the previous Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T01:08:59.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T19:05:58.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2. No other content appears to be affected.
    Difference
    0.1%
    Check dated 2026-02-13T12:23:11.000Z thumbnail image

Stay in the know with updates to UNR844-Cl Eye Drops in Presbyopia: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UNR844-Cl Eye Drops in Presbyopia: Clinical Trial page.